X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (527) 527
humans (514) 514
male (351) 351
female (340) 340
middle aged (338) 338
hematology (320) 320
aged (300) 300
adult (236) 236
oncology (191) 191
multiple myeloma (184) 184
amyloidosis (182) 182
abridged index medicus (150) 150
prognosis (136) 136
aged, 80 and over (135) 135
treatment outcome (126) 126
survival (124) 124
retrospective studies (123) 123
transplantation (118) 118
multiple-myeloma (115) 115
care and treatment (105) 105
diagnosis (104) 104
stem-cell transplantation (100) 100
article (99) 99
primary systemic amyloidosis (95) 95
therapy (91) 91
multiple myeloma - drug therapy (84) 84
medicine, general & internal (76) 76
survival analysis (76) 76
al amyloidosis (73) 73
analysis (71) 71
stem cells (70) 70
chemotherapy (69) 69
multiple myeloma - therapy (68) 68
bortezomib (67) 67
follow-up studies (66) 66
monoclonal gammopathy (66) 66
risk factors (66) 66
dexamethasone (63) 63
transplantation, autologous (63) 63
amyloidosis - therapy (61) 61
disease progression (61) 61
hematology, oncology and palliative medicine (61) 61
survival rate (60) 60
cardiac & cardiovascular systems (59) 59
stem cell transplantation (59) 59
multiple myeloma - mortality (57) 57
multiple myeloma - diagnosis (56) 56
amyloidosis - diagnosis (55) 55
immunoglobulins (52) 52
multiple myeloma - pathology (52) 52
cancer (50) 50
patients (50) 50
thalidomide (50) 50
melphalan (49) 49
disease-free survival (48) 48
immunology (48) 48
amyloidosis - mortality (47) 47
hematopoietic stem cell transplantation (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (45) 45
research (45) 45
biopsy (44) 44
immunoglobulin light chains - blood (43) 43
internal medicine (43) 43
antineoplastic agents - therapeutic use (41) 41
light-chain amyloidosis (41) 41
patient outcomes (41) 41
undetermined significance (41) 41
medical research (39) 39
amyloidosis - pathology (38) 38
health aspects (38) 38
usage (37) 37
bone marrow (36) 36
brain natriuretic peptide (36) 36
high-dose melphalan (36) 36
myeloma (36) 36
amyloid (35) 35
amyloidosis - complications (35) 35
progression (35) 35
risk (35) 35
combined modality therapy (34) 34
thalidomide - analogs & derivatives (34) 34
cohort studies (33) 33
multiple myeloma - blood (33) 33
proteins (33) 33
recurrence (33) 33
cardiomyopathy (32) 32
dexamethasone - administration & dosage (32) 32
lenalidomide (32) 32
mortality (32) 32
multiple myeloma - genetics (32) 32
development and progression (31) 31
echocardiography (31) 31
kaplan-meier estimate (31) 31
medicine, experimental (31) 31
medicine, research & experimental (31) 31
time factors (31) 31
trial (30) 30
cardiac amyloidosis (29) 29
clinical trials and observations (29) 29
immunoglobulin light chains - metabolism (29) 29
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Hematology, ISSN 0361-8609, 08/2017, Volume 92, Issue 8, pp. 814 - 829
Journal Article
American Journal of Hematology, ISSN 0361-8609, 07/2019, Volume 94, Issue 7, pp. 812 - 827
Journal Article
Blood, ISSN 0006-4971, 02/2018, Volume 131, Issue 5, pp. 475 - 476
In this issue of Blood, Palladini et al address one of the most important, yet befuddling questions in immunoglobulin light chain (AL) amyloidosis treatment:... 
LIGHT-CHAIN AMYLOIDOSIS | HEMATOLOGY | Humans | Hypersensitivity | Disease Progression | Immunoglobulin Light-chain Amyloidosis | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 15, pp. 2044 - 2045
In this issue of Blood , Oliva et al report on a series of experiments that have demonstrated that in systemic light chain (AL) plasma cells (PCs), there is a... 
HEMATOLOGY | Index Medicus | Abridged Index Medicus | Inside
Journal Article
Blood, ISSN 0006-4971, 10/2014, Volume 124, Issue 15, pp. 2315 - 2316
In this issue of Blood, Palladini and colleagues address incidence of and risk factors for end-stage renal disease (ESRD) and proffer a new renal response... 
CRITERIA | LIGHT-CHAIN AMYLOIDOSIS | HEMATOLOGY | Biomarkers - metabolism | Amyloidosis - pathology | Kidney - pathology | Humans | Female | Male | Amyloidosis - drug therapy | Immunoglobulin Light Chains - metabolism | Immunoglobulin Light-chain Amyloidosis | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10068, pp. 519 - 527
Journal Article
Blood, ISSN 0006-4971, 06/2011, Volume 117, Issue 24, pp. 6405 - 6406
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2015, Volume 90, Issue 10, pp. 951 - 962
Journal Article